Lumexa Imaging Holdings, Inc. filed its quarterly report on Form 10-Q with the SEC on November 12, 2026, covering the three and nine months ended September 30, 2026, disclosing a return to profitability versus a net loss in the prior-year comparable periods.

Key Highlights

  • Nine-month net income: The company reported net income of $11,640 thousand for the nine months ended September 30, 2026, compared to a net loss of $18,414 thousand for the same period in 2025, according to the filing.
  • Third-quarter revenue: Total revenues for the three months ended September 30, 2026 were $271,973 thousand, up from $258,944 thousand in the same quarter of 2025.
  • Nine-month revenue: Total revenues for the nine months ended September 30, 2026 were $788,672 thousand, compared to $755,347 thousand in the prior-year period.
  • Total assets: Total assets stood at $1,833,136 thousand as of September 30, 2026, versus $1,764,557 thousand at December 31, 2025.
  • Accumulated deficit reduced: The accumulated deficit narrowed to $619,420 thousand at September 30, 2026 from $631,060 thousand at December 31, 2025.
  • Shares outstanding: As of November 12, 2026, the registrant had 96,122,987 shares of common stock outstanding.
  • Interest expense decline: Interest expense for the nine months ended September 30, 2026 was $48,227 thousand, compared to $90,523 thousand for the same period in 2025.

Lumexa Imaging's Financial Results for the Quarter and Nine Months Ended September 30, 2026

Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI), headquartered in Raleigh, North Carolina, disclosed its unaudited condensed consolidated financial results in a 10-Q filing dated November 12, 2026. According to the filing, the company reported net income of $7,178 thousand for the three months ended September 30, 2026, compared to a net loss of $3,501 thousand for the same quarter in 2025. For the nine-month period, net income was $11,640 thousand versus a net loss of $18,414 thousand in the prior year. Basic and diluted earnings per share for the nine months were each $0.12, compared to a loss per share of $0.26 in the prior-year period.

The filing reported total revenues of $271,973 thousand for the third quarter of 2026, driven by net patient service revenue of $201,719 thousand and management fee and other revenue, related party of $52,574 thousand. Cost of operations, excluding depreciation and amortization, was $225,571 thousand for the quarter. Equity in earnings of unconsolidated affiliates contributed $22,846 thousand to third-quarter results, up from $17,990 thousand a year earlier. Income from operations for the third quarter was $28,113 thousand, compared to $30,340 thousand in the same period of 2025.

On the balance sheet, total equity increased to $634,083 thousand at September 30, 2026 from $586,123 thousand at December 31, 2025. Long-term debt, less current maturities, was $821,524 thousand. The filing noted a loss on extinguishment and modification of debt of $1,053 thousand for the nine months ended September 30, 2026, with no comparable amount in the prior-year period. The company also disclosed consolidated variable interest entities whose assets and liabilities are included in the condensed consolidated balance sheets, with VIE accounts receivable totaling $62,320 thousand as of September 30, 2026.

What Was Disclosed

Lumexa Imaging Holdings filed its 10-Q for the quarterly period ended September 30, 2026, reporting a swing to profitability over both the quarter and nine-month period, higher total revenues year over year, and growth in total assets and equity relative to year-end 2025.